ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Healthtech Company Veriheal Releases Gender-Focused Medical Cannabis Preference Report

Veriheal’s Anonymous National Survey Data Show Which Cannabis Product Categories Are Most Sought, Coupled With Patient Quality of Life Goals

Healthcare technology company Veriheal today announced findings from its annual Medical Cannabis Preference Report, a segmented survey of registered medical cannabis patients that illuminates which types of cannabis products are preferred by men and women and what product offerings patients most hope to see available in dispensaries.

Veriheal possesses the largest network of physicians in the medical cannabis space and helps patients book appointments for medical cannabis card certifications and wellness visits. The company drew data from 125,000 patient signups registered in 2021, surveying cannabis use preferences, user experience, medical conditions and several other variables which factor into their cannabis use.

The findings in the Report include a strong preference by men for cannabis flower over edibles, while women are more agnostic. However, roughly 30% of patients surveyed would prefer to see more edibles on the market, compared to an average of 21.5% of respondents who said they wished more flower were available.

Veriheal’s Report offers specificity of data at the intersection of health and cannabis that has historically been hard to come by.

“Veriheal seeks to give the patient community a voice, while also boosting research that helps cannabis companies make better, more tailored products and connect patients with the medicine they need,” said Anthony Dutcher, Veriheal CMO.

Other data findings touched on patient health goals. Men listed pain relief (69%) and relaxation (67%) most frequently, while women led with symptom relief of stress (72%) and pain (69%). Women were also more likely to utilize medical cannabis for sleep and nausea than men.

The full report can be accessed here.

About Veriheal

Veriheal is a healthcare technology company that is the largest facilitator of medical marijuana cards in the nation. Its mission is to educate and advocate on behalf of patients and secure their safe access to regulated medical cannabis products. The company has a culture of open communication and transparency with its clients, and operates as a concierge service to ensure HIPAA compliant connections between patients and physicians via its proprietary platform. Visit veriheal.com for more information.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.